Monthly Archives: August 2013

Ultragenyx Receives Approval of Clinical Trial Application (CTA) for a Phase 1/2 Trial Testing UX003 in MPS VII

Ultragenyx Receives Approval of Clinical Trial Application (CTA) for a Phase 1/2 Trial Testing UX003 in Mucopolysaccharidosis Type 7 (MPS 7)   NOVATO, CA – August 14, 2013 – Ultragenyx …

Posted in News | Leave a comment

Give to the 2013 Annual Fund: Chair, Stacy Peters

Have you donated to the 2013 Annual Fund yet?

Your donation to the National MPS Society’s Annual Fund helps move our Mission forward in finding therapies and cures for children who need them and supporting our families.

Posted in News | Leave a comment

The Center for Orphan Disease Research and Therapy announces a Request for Applications to support research for improved therapies for patients with MPS I

The Center for Orphan Disease Research and Therapy announces a Request for Applications (RFA) to support research on the development of improved therapies for patients with syndromes due to MPS …

Posted in News, Uncategorized | Leave a comment

Voting has begun for 2014 Board of Directors

The Nomination process has been completed. If you are a current member of the Society, you received an email on Tuesday September 17th with online directions for voting.

Posted in News | Leave a comment